Home / Current Issue / Paper 1706891
Telehealth in Chronic Diseases Monitoring Focus on Diabetes, Hypertension and Pulmonary
Subject area: Arts, Social Sciences and Humanities · Area of research: Health
Abstract
Background Chronic diseases such as diabetes, hypertension, and pulmonary conditions significantly contribute to global morbidity and mortality. Managing these conditions requires consistent monitoring, timely interventions, and patient engagement, which traditional healthcare models often fail to provide. Telehealth, leveraging digital communication technologies, offers transformative potential in chronic disease management by improving accessibility, real-time monitoring, and personalized care. Despite growing evidence of telehealth's efficacy, a systematic analysis comparing its impact across these chronic conditions remains underexplored. Methodology A systematic review was conducted to evaluate the effectiveness of telehealth interventions in managing diabetes, hypertension, and pulmonary conditions. A comprehensive search strategy was applied to four databases: PubMed, Scopus, Web of Science, and Google Scholar. The inclusion criteria focused on studies evaluating telehealth technologies, such as remote monitoring and virtual consultations, published between 2010 and 2024. Data on study design, interventions, and outcomes were extracted and synthesized thematically to compare telehealth's impact across the three diseases. Results The review included 11 studies representing diverse geographic regions and healthcare settings. Telehealth interventions improved glycemic control in diabetes, reducing HbA1c levels by 0.5%?0.9%. In hypertension, telemonitoring led to a mean systolic blood pressure reduction of 10 mmHg and diastolic reduction of 6 mmHg. For pulmonary conditions, telehealth reduced hospital admissions by 25% and emergency visits by 40%, with a 12% improvement in lung function (FEV1). Common benefits included enhanced patient adherence, reduced healthcare utilization, and improved satisfaction. However, challenges such as technological barriers, adherence sustainability, and provider training were noted. Conclusion Telehealth demonstrates significant efficacy in managing chronic diseases, improving clinical outcomes, patient engagement, and healthcare accessibility. While its integration into healthcare systems shows promise, addressing implementation challenges, including infrastructure and training, is essential for maximizing its potential. Future research should explore long-term sustainability, cost-effectiveness, and integration with emerging technologies to optimize telehealth interventions in chronic disease management.
Keywords
Telehealth, Diabetes Management, Hypertension Control, Pulmonary Monitoring, Chronic Disease Management, Systematic Review.
References
[1] Bashshur, R. L., Shannon, G. W., Smith, B. R., & Alverson, D. C. (2014). The empirical foundations of telemedicine interventions for chronic disease management. Telemedicine and e-Health, 20(9), 769–800. https://doi.org/10.1089/tmj.2014.9981
[2] Chumbler, N. R., Neugaard, B., Ryan, P., Qin, H., & Joo, Y. (2005). An observational study of veterans with diabetes receiving weekly or daily home telehealth monitoring. Journal of Telemedicine and Telecare, 11(3), 150–156. https://doi.org/10.1258/1357633054068954
[3] de Jong, C. C., Ros, W. J. G., & Schrijvers, G. (2014). The effects of telehealth on chronic disease self-management: A systematic review. Health Education & Behavior, 41(2), 173–182. https://doi.org/10.1177/1090198113490721
[4] Edelman, D., McDuffie, J. R., Oddone, E., Gierisch, J. M., & Williams, J. W. (2012). Shared medical appointments for patients with diabetes mellitus: A systematic review. Journal of General Internal Medicine, 27(1), 99–107. https://doi.org/10.1007/s11606-011-1821-8
[5] Ekeland, A. G., Bowes, A., & Flottorp, S. (2010). Effectiveness of telemedicine: A systematic review of reviews. International Journal of Medical Informatics, 79(11), 736–771. https://doi.org/10.1016/j.ijmedinf.2010.08.006
[6] Farmer, A., Gibson, O. J., Tarassenko, L., & Neil, A. (2005). A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabetic Medicine, 22(10), 1372–1378. https://doi.org/10.1111/j.1464-5491.2005.01627.x
[7] Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2020). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). GOLD Publications. Retrieved from https://goldcopd.org
[8] Huygens, M. W. J., Voogdt-Pruis, H. R., Wouters, M., Meurs, M. M., van Lettow, B., Kleijweg, C., & Friele, R. D. (2021). The uptake and use of telemonitoring in chronic care between 2014 and 2019: Nationwide survey among patients and health care professionals in the Netherlands. Journal of Medical Internet Research, 23(5), e24908. https://doi.org/10.2196/24908
[9] Kitsiou, S., Paré, G., & Jaana, M. (2015). Effects of home telemonitoring interventions on patients with chronic heart failure: An overview of systematic reviews. Journal of Medical Internet Research, 17(3), e63. https://doi.org/10.2196/jmir.4174
[10] Kvedar, J., Loughlin, K. R., & Marceau, L. D. (2006). Home blood pressure monitoring: A technology whose time has come. Journal of Clinical Hypertension, 8(2), 114–117. https://doi.org/10.1111/j.1524-6175.2005.04884.x
[11] McLean, S., Nurmatov, U., Liu, J. L., & Pagliari, C. (2011). Telehealthcare for chronic obstructive pulmonary disease: Cochrane review and meta-analysis. British Journal of General Practice, 61(589), e739–e749. https://doi.org/10.3399/bjgp11X601389
[12] Omboni, S., & McManus, R. J. (2021). Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: An international expert position paper. Hypertension, 78(5), 1338–1350. https://doi.org/10.1161/HYPERTENSIONAHA.121.18004
[13] Paré, G., Jaana, M., & Sicotte, C. (2007). Systematic review of home telemonitoring for chronic diseases: The evidence base. Journal of the American Medical Informatics Association, 14(3), 269–277. https://doi.org/10.1197/jamia.M2270
[14] Polisena, J., Tran, K., Cimon, K., Hutton, B., McGill, S., & Palmer, K. (2009). Home telehealth for diabetes management: A systematic review and meta-analysis. Diabetes, Obesity & Metabolism, 11(10), 913–930. https://doi.org/10.1111/j.1463-1326.2009.01041.x
[15] Rahimi, K., Nazarzadeh, M., Pinho-Gomes, A. C., Woodward, M., Salimi-Khorshidi, G., Ohkuma, T., Fitzpatrick, R., Tarassenko, L., Denis, M., & Cleland, J. (2020). Home monitoring with technology-supported management in chronic heart failure: A randomised trial. Heart, 106(20), 1573–1578. https://doi.org/10.1136/heartjnl-2020-316668
[16] Renders, C. M., Valk, G. D., Griffin, S. J., Wagner, E. H., Eijk, J. T. M., & Assendelft, W. J. J. (2001). Interventions to improve the management of diabetes mellitus in primary care, outpatient, and community settings. The Cochrane Database of Systematic Reviews, 2001(1), CD001481. https://doi.org/10.1002/14651858.CD001481
[17] Smith, A. C., Thomas, E., Snoswell, C. L., Haydon, H., Mehrotra, A., Clemensen, J., & Caffery, L. J. (2020). Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). Journal of Telemedicine and Telecare, 26(5), 309–313. https://doi.org/10.1177/1357633X20916567
[18] World Health Organization (WHO). (2021). Chronic obstructive pulmonary disease (COPD). Retrieved from https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
[19] World Health Organization (WHO). (2021). Diabetes. Retrieved from https://www.who.int/news-room/fact-sheets/detail/diabetes
[20] World Health Organization (WHO). (2021). Hypertension. Retrieved from https://www.who.int/news-room/fact-sheets/detail/hypertension
How to cite this paper
@article{1706891,
author = {Olayiwola Zainab Ajoke, Popoola Feyisayo Favour, Eneyo Aya-afon Efre, Erorun Mofe, Agwasim Sarah Ngozi; Kawojue Ismail Temitayo},
title = {Telehealth in Chronic Diseases Monitoring Focus on Diabetes, Hypertension and Pulmonary},
journal = {Iconic Research And Engineering Journals},
year = {2025},
volume = {8},
number = {7},
pages = {714-728},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1706891.pdf},
abstract = {Background
Chronic diseases such as diabetes, hypertension, and pulmonary conditions significantly contribute to global morbidity and mortality. Managing these conditions requires consistent monitoring, timely interventions, and patient engagement, which traditional healthcare models often fail to provide. Telehealth, leveraging digital communication technologies, offers transformative potential in chronic disease management by improving accessibility, real-time monitoring, and personalized care. Despite growing evidence of telehealth's efficacy, a systematic analysis comparing its impact across these chronic conditions remains underexplored.
Methodology
A systematic review was conducted to evaluate the effectiveness of telehealth interventions in managing diabetes, hypertension, and pulmonary conditions. A comprehensive search strategy was applied to four databases: PubMed, Scopus, Web of Science, and Google Scholar. The inclusion criteria focused on studies evaluating telehealth technologies, such as remote monitoring and virtual consultations, published between 2010 and 2024. Data on study design, interventions, and outcomes were extracted and synthesized thematically to compare telehealth's impact across the three diseases.
Results
The review included 11 studies representing diverse geographic regions and healthcare settings. Telehealth interventions improved glycemic control in diabetes, reducing HbA1c levels by 0.5%?0.9%. In hypertension, telemonitoring led to a mean systolic blood pressure reduction of 10 mmHg and diastolic reduction of 6 mmHg. For pulmonary conditions, telehealth reduced hospital admissions by 25% and emergency visits by 40%, with a 12% improvement in lung function (FEV1). Common benefits included enhanced patient adherence, reduced healthcare utilization, and improved satisfaction. However, challenges such as technological barriers, adherence sustainability, and provider training were noted.
Conclusion
Telehealth demonstrates significant efficacy in managing chronic diseases, improving clinical outcomes, patient engagement, and healthcare accessibility. While its integration into healthcare systems shows promise, addressing implementation challenges, including infrastructure and training, is essential for maximizing its potential. Future research should explore long-term sustainability, cost-effectiveness, and integration with emerging technologies to optimize telehealth interventions in chronic disease management.},
keywords = {Telehealth, Diabetes Management, Hypertension Control, Pulmonary Monitoring, Chronic Disease Management, Systematic Review.},
month = {January},
}